Literature DB >> 3007577

Mechanism of action of glucocorticosteroids. Inhibition of T cell proliferation and interleukin 2 production by hydrocortisone is reversed by leukotriene B4.

J S Goodwin, D Atluru, S Sierakowski, E A Lianos.   

Abstract

The mechanism whereby glucocorticosteroids are immunosuppressive is unknown. One potential mechanism of action of these compounds is inhibition of arachidonic acid metabolism. We found that the inhibition of lymphocyte proliferation by hydrocortisone or dexamethasone was mimicked by nonspecific lipoxygenase inhibitors and also by a specific 5-lipoxygenase inhibitor, but not by a specific cyclooxygenase inhibitor. Mitogen-stimulated cultures of T cells produce approximately 5 X 10(-9) M leukotriene B4 (LTB4) in 24 h. This production of LTB4 is completely inhibited by concentrations of hydrocortisone or lipoxygenase inhibitors that inhibit mitogen-induced [3H]thymidine incorporation. The inhibition of lymphocyte proliferation by either hydrocortisone or by the 5-lipoxygenase inhibitor was totally reversed by LTB4 but not by leukotriene C4 or leukotriene D4. LTB4 had no effect on the inhibition of lymphocyte proliferation by noncorticosteroids such as prostaglandin E2, histamine, or gamma-interferon. The inhibition of interleukin 2 (IL-2) production by hydrocortisone or dexamethasone was also completely reversed by exogenous LTB4. LTB4 alone did not cause IL-2 production or cell proliferation when added to resting lymphocytes. Thus, endogenous LTB4 production appears to be necessary but not sufficient for phytohemagglutinin-induced IL-2 production and lymphocyte proliferation. Glucocorticosteroids inhibit IL-2 production and lymphocyte proliferation by inhibiting endogenous LTB4 production.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3007577      PMCID: PMC424468          DOI: 10.1172/JCI112427

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

1.  Corticosteroids inhibit prostaglandin production by rheumatiod synovia.

Authors:  F Kantrowitz; D R Robinson; M B McGuire; L Levine
Journal:  Nature       Date:  1975-12-25       Impact factor: 49.962

2.  Hydrocortisone inhibits prostaglandin production by mouse fibrosarcoma cells.

Authors:  A H Tashjian; E F Voelkel; J McDonough; L Levine
Journal:  Nature       Date:  1975-12-25       Impact factor: 49.962

3.  Effect of lipoxygenase metabolites of arachidonic acid on proliferation of human T cells and T cell subsets.

Authors:  N Gualde; D Atluru; J S Goodwin
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

4.  On the formation of thromboxane B2 and 12l-hydroxy-5,8,10,14-eicosatetraenoic acid (12 ho-20:4) in tissues from the guinea pig.

Authors:  M Hamberg
Journal:  Biochim Biophys Acta       Date:  1976-06-22

5.  Effect of dexamethasone on in vivo prostanoid production in the rabbit.

Authors:  A Náray-Fejes-Tóth; G Fejes-Tóth; C Fischer; J C Frölich
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

6.  Corticosteroids inhibit prostaglandin release from perfused mesenteric blood vessels of rabbit and from perfused lungs of sensitized guinea pig.

Authors:  R J Gryglewski; B Panczenko; R Korbut; L Grodzinska; A Ocetkiewicz
Journal:  Prostaglandins       Date:  1975-08

7.  Mechanism of steroid action in inflammation: inhibition of prostaglandin synthesis and release.

Authors:  Y Floman; U Zor
Journal:  Prostaglandins       Date:  1976-09

8.  Arachidonic acid metabolism among human mononuclear leukocytes. Lipoxygenase-related pathways.

Authors:  M E Goldyne; G F Burrish; P Poubelle; P Borgeat
Journal:  J Biol Chem       Date:  1984-07-25       Impact factor: 5.157

9.  Inhibition of the antigen activated T cell response by methylprednisolone is caused by inhibition of interleukin-2 (IL-2) production.

Authors:  B Randazzo; T Hirschberg; H Hirschberg
Journal:  Int J Immunopharmacol       Date:  1984

10.  Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell.

Authors:  J S Goodwin; A D Bankhurst; R P Messner
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

View more
  24 in total

1.  Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura.

Authors:  F Mollica; S Li Volti; R Garozzo; G Russo
Journal:  Eur J Pediatr       Date:  1992-02       Impact factor: 3.183

2.  Early treatment with oral immunosuppressants in severe proteinuric purpura nephritis.

Authors:  Salvatore Li Volti; Giovanni Li Volti
Journal:  Pediatr Nephrol       Date:  2003-09-12       Impact factor: 3.714

Review 3.  Control of humoral immune responses by arachidonic acid metabolites.

Authors:  T W Behrens; J S Goodwin
Journal:  Agents Actions       Date:  1989-01

Review 4.  Immunological aspects of antiviral therapy.

Authors:  M Peters
Journal:  Springer Semin Immunopathol       Date:  1990

Review 5.  Regulation of T cell activation by leukotriene B4.

Authors:  J S Goodwin
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

6.  Lipoxygenase products in the urine correlate with renal function and body temperature but not with acute transplant rejection.

Authors:  Stephan W Reinhold; Thomas Scherl; Benjamin Stölcker; Tobias Bergler; Ute Hoffmann; Christian Weingart; Miriam C Banas; Dmitrij Kollins; Martin C Kammerl; Bernd Krüger; Bernhard Kaess; Bernhard K Krämer; Bernhard Banas
Journal:  Lipids       Date:  2012-12-29       Impact factor: 1.880

Review 7.  Mononuclear phagocytes and eicosanoids: aspects of their synthesis and biological activities.

Authors:  U F Schade; I Burmeister; E Elekes; R Engel; D T Wolter
Journal:  Blut       Date:  1989-12

8.  Increased natural killer resistance to cyclosporine A by continuous doses of dexamethasone in rats.

Authors:  E Kamio; Y Sakamoto; T Kimura; H Takakuwa; M Sakurai; J I Hosokawa; K Nakagawa; F Yoshida; K Tagami
Journal:  Immunology       Date:  1997-11       Impact factor: 7.397

Review 9.  Exercise and the immune system. Natural killer cells, interleukins and related responses.

Authors:  R J Shephard; S Rhind; P N Shek
Journal:  Sports Med       Date:  1994-11       Impact factor: 11.136

Review 10.  Perioperative glucocorticoid coverage. A reassessment 42 years after emergence of a problem.

Authors:  M Salem; R E Tainsh; J Bromberg; D L Loriaux; B Chernow
Journal:  Ann Surg       Date:  1994-04       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.